Molecular pathology of thyroid cancer: diagnostic and clinical implications. - Wikidata - wikimedia - TriplyDB

Molecular pathology of thyroid cancer: diagnostic and clinical implications.

Molecular pathology of thyroid cancer: diagnostic and clinical implications.

http://www.wikidata.org/entity/Q37337504

about

BRAF activates and physically interacts with PAK to regulate cell motility STAT3 negatively regulates thyroid tumorigenesis Quantitative analysis of suspicious thyroid nodules by contrast-enhanced ultrasonography Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues.Identification of Long Noncoding RNAs Deregulated in Papillary Thyroid Cancer and Correlated with BRAFV600E Mutation by Bioinformatics Integrative Analysis.Differential expression of a set of genes in follicular and classic variants of papillary thyroid carcinoma.Mutationally activated BRAF(V600E) elicits papillary thyroid cancer in the adult mouse Hypoxia-inducible factor in thyroid carcinoma Warthin-Like Papillary Thyroid Carcinoma Associated with Lymphadenopathy and Hashimoto's Thyroiditis.Standard and emerging therapies for metastatic differentiated thyroid cancer.BRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature Review BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma.Papillary thyroid carcinoma: differential diagnosis and prognostic values of its different variants: review of the literature.Herpes and polyoma family viruses in thyroid cancer.Clinical implication of the BRAFV600E mutation in papillary thyroid carcinoma.Evolving approaches to patients with advanced differentiated thyroid cancer Altered expression of mir-222 and mir-25 influences diverse gene expression changes in transformed normal and anaplastic thyroid cells, and impacts on MEK and TRAIL protein expression.New developments in the diagnosis and treatment of thyroid cancer.Papillary thyroid carcinoma with lung metastasis arising from dyshormonogenetic goiter: a case report Dual inhibition of mitogen-activated protein kinase kinase and mammalian target of rapamycin in differentiated and anaplastic thyroid cancer.Diagnostic markers and prognostic factors in thyroid cancer.Deregulation of microRNA expression in thyroid tumors.Thyroid stem cells--danger or resource?Anaplastic thyroid cancer: a comprehensive review of novel therapy.Targeted therapy in refractory thyroid cancer: current achievements and limitations.Differentiated thyroid cancers: a comprehensive review of novel targeted therapies.Synchronous occurrence of medullary and papillary carcinoma of the thyroid in a patient with cutaneous melanoma: determination of BRAFV600E in peripheral blood and tissues. Report of a case and review of the literature.Role of BRAF molecular analysis in the management of papillary thyroid carcinoma: analysis of cytological and histological samples.Treatment of advanced thyroid cancer: role of molecularly targeted therapies.Overview of Genetically Engineered Mouse Models of Papillary and Anaplastic Thyroid Cancers: Enabling Translational Biology for Patient Care Improvement.ICRP Publication 131: Stem Cell Biology with Respect to Carcinogenesis Aspects of Radiological Protection.Restoration of Brain Acid Soluble Protein 1 Inhibits Proliferation and Migration of Thyroid Cancer Cells.Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience The metabolomics and lipidomics window into thyroid cancer research.The role of molecular diagnostic testing in the management of thyroid nodules.Multicompartment metabolism in papillary thyroid cancer Integrating omics data and protein interaction networks to prioritize driver genes in cancer.Thyroid cancer in a patient with Lynch syndrome - case report and literature review.Management of differentiated thyroid cancer of the follicular epithelium.Overexpression of EphB4, EphrinB2, and epidermal growth factor receptor in papillary thyroid carcinoma: A pilot study.

P2860

Q28248127-E7C3420D-7F95-403F-9F56-F96F4617E048 Q28505424-F206B1C6-9AA0-4D70-9457-A1F2F9FF34EE Q30402984-3A8AB997-05AE-4F38-A20D-3DE2B738203C Q31141133-06FB4A8C-207F-4BFB-9D7C-88267851A66F Q33686833-35F47B40-4570-4CB4-A24C-51F30A5D4128 Q34179794-6131C9D1-8C76-44D4-9D18-3E532D442693 Q35022217-DFD65B55-B882-4A1F-9E90-FD52A6724F21 Q35099457-F24562C9-A884-49E5-A9AB-6DC93CF397B2 Q35188948-0C85FDF6-0542-4420-91E9-016968174C4A Q35583906-C0EB60CE-595D-4D75-96A2-C6D3A1A59A8E Q35609167-C79AF849-7C7A-41DD-9126-B58BC9CA0A2A Q35755353-0E2ADA4C-B361-47CB-89CE-115421D9626B Q35825451-1FAEAE3C-1E96-4FAA-93E2-8DBB5F4EAD76 Q36640448-3D8CDA03-4049-4A08-ABF9-22C796918999 Q36863490-861C9EA4-ED63-4E54-8958-CEE80C375001 Q36864736-CE90ABC1-213D-46AA-B5DC-4F36AF8B1686 Q37071712-B560979F-A082-4B1A-81EA-FE8A2BB39BA0 Q37238757-511E6295-724E-4D62-B84C-45606ED67BB2 Q37328007-96E0B7B9-1D3C-4983-A8AD-21BE467C5DE5 Q37379562-78772453-8DC6-48B0-BF6C-EB6A384C325B Q37620399-4C38B3A9-1B00-449C-AEBF-4CA5F35A2123 Q37640384-FE98A5E4-0B82-4214-80D0-846B44D5F844 Q37750480-F442DF90-F202-44EE-B780-30CFD20DADB5 Q37854708-08704BFC-A07D-4739-8369-F3F97F8186C0 Q37875081-158C3B89-4CEC-4A12-A284-B15E46BDAE26 Q37988566-4EFAA3F2-31D3-48A6-BE95-712790F41A54 Q38214480-24CE4578-2066-446F-B16F-A0AB8011BCC8 Q38390524-4C5487F1-E597-4ED8-9A93-C49D02465B80 Q38579925-705B0EB2-598D-4AF0-AC57-EB342E944003 Q38581928-E83EDC8E-772C-4733-8C4D-E7EE6A479B01 Q38659248-58CFF489-BCA9-443D-BD4F-0173A201CDA0 Q38766140-34EC7213-E262-4588-A765-B9E892922753 Q38860726-0D4A032E-7A91-4CB8-84BC-0142EE81774A Q38996666-5A21060D-B201-485D-BFE3-AA0391264575 Q39250953-2C90BF5B-E515-4E1C-A1B1-DF55638B1950 Q41652439-7AB1B49A-74BF-4A20-9D6F-49B592EBF87B Q41708970-830AC6C3-86D8-464E-8EF1-9637A48DBAE2 Q42339140-147C7521-CFD0-4D75-8527-6071ABD743D6 Q44901402-1B7DC230-CAAC-4815-9ABF-5D50F8110FC0 Q45232514-011BA1F9-C914-4E24-BB0D-0821001096F3

P2860

Molecular pathology of thyroid cancer: diagnostic and clinical implications.

http://www.wikidata.org/entity/Q37337504

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Molecular pathology of thyroid cancer: diagnostic and clinical implications.

@en

Molecular pathology of thyroid cancer: diagnostic and clinical implications.

@nl

type

label

Molecular pathology of thyroid cancer: diagnostic and clinical implications.

@en

Molecular pathology of thyroid cancer: diagnostic and clinical implications.

@nl

prefLabel

Molecular pathology of thyroid cancer: diagnostic and clinical implications.

@en

Molecular pathology of thyroid cancer: diagnostic and clinical implications.

@nl

P1433

Q37337504-7DD6B843-D791-49FB-9ACB-5ECB74EDDFCD

P1476

Q37337504-4600D549-D63E-449F-A6A2-7C2AF6357DF6

P2093

Q37337504-0E2DB9B3-A962-40E0-BAEC-9FCE81A50FB7

Q37337504-467DD716-5444-4A2A-B2D0-88AF89246F3A

P2860

Q37337504-00F9FA3C-964A-4928-90B3-3AFE9E98EDE6

Q37337504-0604B832-25B4-4D61-B437-4406F421D243

Q37337504-0868C94B-ED17-484F-A08D-E8A82B547B71

Q37337504-0DCD30F8-BF04-466E-A13C-2000BB1538A4

Q37337504-19BE2DDC-B14E-4A31-981E-BD30594D9788

Q37337504-1C4820B1-8F06-4C8F-8916-D057F4328EC4

Q37337504-1CA91129-42D2-4F83-A06F-A7935160257A

Q37337504-1D0C418F-2785-4A85-A27B-9AFB6F383F98

Q37337504-2063C071-6291-4C3A-B7AD-76585265EF27

Q37337504-213CD89E-5AA2-452E-A38A-47DD88B89BF6

P304

Q37337504-834463F9-7C48-46C1-B529-5C773962A222

P31

Q37337504-9EFCFF30-275B-43F0-AEFB-A0118B584F97

P356

Q37337504-204725EB-EB6E-40E5-9330-15F6B20B647E

P433

Q37337504-054DF60C-3019-44CA-8406-A19F5D8F70A9

P478

Q37337504-F31658CF-13EC-413E-9448-2358B59F2E03

P577

Q37337504-FC66F82D-6CD5-4C8A-BD12-A59F146E72E2

P5875

Q37337504-2B18D7C1-7D06-4C35-9592-9C0E06D35CD5

P698

Q37337504-D4D92DA2-2684-4F55-8773-EF11051E68C9

P921

Q37337504-2027d61f-1427-4147-bdb4-84aa19b2d1e2

Q37337504-b7c1a10d-b1e2-482c-9df3-ec974418757b

P932

Q37337504-DE803A36-929F-4769-939B-CCC2900EB471

P356

J.BEEM.2008.09.017

P1433

Best Practice and Research: Clinical Endocrinology and Metabolism

P1476

Molecular pathology of thyroid cancer: diagnostic and clinical implications.

@en

P2093

James A Fagin

http://www.w3.org/2001/XMLSchema#string

Nicholas Mitsiades

http://www.w3.org/2001/XMLSchema#string

P2860

A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.

High frequency of mutations of the PIK3CA gene in human cancers

PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas

BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas

Biochemical analysis of MEK activation in NIH3T3 fibroblasts. Identification of B-Raf and other activators

P304

955-969

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BEEM.2008.09.017

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23554786

http://www.w3.org/2001/XMLSchema#string

P698

19041825

http://www.w3.org/2001/XMLSchema#string

P921

P932

2615540

http://www.w3.org/2001/XMLSchema#string